This article describes the main pathways of carbohydrate metabolism in man. It should be read in conjunction with the subsequent article on Hypoxia (p. 251), to which it forms an introduction.
In section I a brief account is given of the catabolism and anabolism of glucose and tissue variations are mentioned. In section II stress is laid on the mechanism whereby these metabolic pathways are regulated. Section III gives a brief account of the changes which occur if hypoxia develops.
SECTION I: BASIC METABOLIC PATHWAYS
The cell can be divided into organelles, such as nuclei, mitochondria, microsomes, etc., and a nonparticulate portion known as the cytosol. Different biochemical functions are associated with these cell fractions. Glycolysis is a cytosol activity, whereas gluconeogenesis is associated with mitochondria, cytosol and microsomes. The citrate cycle and the electron transport and oxidative phosphorylating systems are associated with the mitochondria. This compartmentation of metabolic pathways allows control of a pathway situated in one compartment by a pathway situated in another compartment, e.g. glycolysis (in the cytosol) regulated by the concentration of a citrate cycle intermediate which diffuses out of the mitochondria into the cytosol (see section II (0).
This is the main pathway of glucose catabolism. 1 mole of glucose-6-phosphate generates 2 molecules of adenosine triphosphate (ATP) when glycolysed to pyruvate (i.e., anaerobic breakdown), whereas complete oxidation (through the Citrate Cycle and Electron Transport System) generates 38 molecules of ATP. Therefore a cell catabolizing glucose under anaerobic conditions requires to use about twenty times more glucose Sols, 1968) .
to obtain the same energy as can be obtained aerobically.
The basic glycolytic pathway is shown in figure  1 together with the main branch points. It consists of two sequential pathways-the glucose phosphorylation pathway and the main glycolytic pathway.
Glycolysis has a nicotinamide adenine dinucleotide (NAD-previously known as DPN) dependent reaction (catalyzed by the enzyme glyceraldehyde phosphate dehydrogenase). This implies mechanisms in the cytoplasm for reoxidizing NADH. NADH cannot cross the mitochondrial membrane and thus the NADH produced in the cytosol cannot be re-oxidized by the mitochondria. The following pathways are common routes for the re-oxidizing of glycolytically generated NADH.
(a) Lactate dehydrogenase pathway. This is a "blind alley" pathway because it requires a continual drain of lactate (the carbon product of anaerobic glycolysis) in order to re-oxidize NADH. The lactate diffuses into the blood and it can be used by other cells to produce glycogen, glucose or be metabolized through the citrate cycle.
(b) Oxaloacetate cycle. This pathway re-oxidizes NADH to NAD and concurrently reduces NADP (nicotinamide adenine dinucleotide phosphatepreviously known as TPN) to NADPH which can be utilized for biosynthetic reactions ( fig. 2) .
(c) Transfer of reducing equivalents between mitochondria and the cytosol. Another method of handling NADH generated in the cytosol is to pass reducing equivalents into the mitochondria by a "shuttle" mechanism as proposed by BRITISH JOURNAL OF ANAESTHESIA Chappell and Robinson (see Greville, 1968) (fig. 3 ). This mechanism can only operate when the mitochondrial NADH is being oxidized.
(ii) Gluconeogenesis. This is the pathway of glucose synthesis from non-carbohydrate substances such as lactate, glycerol or amino-acids. It occurs in liver and kidney. This pathway provides glucose for the maintenance of blood glucose concentration and it is maximally operative in fasting animals. Although generally thought of as being a reversal of glycolysis, it differs from glycolysis by using four non-glycolytic enzymes ( fig. 4 ). The compartmentation of the pathway between mitochondria, cytosol and microsomes is of importance when the regulatory activity or the gluconeogenic pathway is considered (section II).
Note that the reaction phosphoenolpyruvate-> pyruvate ( fig. 1 ) catalyzed by pyruvate kinase is not reversible in liver and kidney cortex (hence the need for enzymes (i) and (ii), fig. 4 ) but is reversible in muscle, where neither pyruvate carboxylase nor phosphenolpyruvate carboxykinase is present. Glucose-6-phosphatase is not found in muscle; therefore reversal of glycolysis in muscle will produce glycogen for future internal energy requirements.
Note that reactions (i) and ( Further aspects of gluconeogenesis will be described in section II.
(iii) Citrate cycle.
Morphologically this metabolic pathway is associated with the mitochondria. It catabolizes pyruvate to carbon dioxide, water and hydrogen. The hydrogen produced is in the form of flavoprotein bound (FAD containing protein), NAD or NADP. The cycle does not produce energy (except for guanosine triphosphate-GTP) but the hydrogen is passed through the electron (iv) Electron transport and oxidative phosphorylation systems. The electron transport system, together with the oxidative phosphorylation system, is found in the inner membrane or mitochondria. This membrane is composed of repeating units of a characteristic shape (fig. 6) .
The electron transport system is linearly arranged along the repeating unit ( fig. 7) . Electrons are thought to flow from one carrier to the next by the carrier molecules expanding and contracting-a process likened to peristalsis.
Complexes 1, 3 and 4 also possess the ability to produce ATP from ADP and P. This is oxidative phosphorylation. Thus the energy obtained by oxidizing NADH and succinate is transformed head piece
FIG. 6
The repeating unit of the inner mitochondrial membrane (after Green and Maclennan, 1967) . into chemical energy in the form of ATP which can be considered as the chemical energy currency of the cell.
(v) Tissue variations in metabolic pathways. The total consumption of oxygen, in man, is about 16 moles/day. Of this, brain consumes 4 moles, liver 3 moles and kidneys 1 mole. In addition to the different oxygen demands of the tissues there is also considerable variation in the type of metabolic fuels used.
(a) Brain. The absolute dependence of the brain on an adequate glucose and oxygen supply is well known. Recent work has shown that during fasting, however, the glucose uptake of the brain diminishes and aceto-acetate and /3-OH-butyrate become important metabolic fuels. Owen and his colleagues (1967) showed that following an overnight fast 20 per cent of the fuel consumption of the brain was derived from ketone bodies. Following 8 days of fasting twice as much energy was obtained from the ketone bodies as was obtained from glucose. However, even after 40 days of fasting there was still a demand for glucose to the extent of 20 per cent of the fuel used.
(b) Liver. This organ is extremely versatile, using amino-acids, fatty acids or glucose as metabolic fuel depending on their availability.
(c) Kidney. The cortex and medulla must be considered separately. The cortex is extremely active metabolically, utilizing fatty acids for energy and amino-acids, lactate and pyruvate for Both skeletal and heart muscle appear to make minimal use of blood glucose and RQ values indicate that fat is the principal source of energy. When muscle is adequately oxygenated there is an uptake of lactate from the blood but this is reduced when the muscle is inadequately oxygenated and instead lactate and pyruvate are produced together with an increase in glucose uptake.
SECTION II: CONTROL OF METABOLIC PATHWAYS
This topic presently forms the object of a great deal of research effort and it is complex and difficult. An attempt is made here to outline some aspects of the regulation of metabolic pathways as they affect the postabsorptive and fasting man.
It is necessary to outline the theory of allosteric control of enzyme activity before describing the regulation of glycolysis.
An allosteric enzyme is one which has its activity controlled by substances (allosteric effectors) which may or may not be involved in the enzyme reaction (substrates or cofactors). These effectors bind to allosteric sites and these, by definition, are always separate from the active sites. Two types of allosteric effector can be distinguished-an allosteric inhibitor which decreases the enzyme activity and an allosteric de-inhibitor which releases the enzyme inhibition induced by the allosteric inhibitor.
The Pasteur effect (the inhibition of glycolysis by oxygen) and its reverse (the stimulation of glycolysis by anoxia) can be at least partially explained in terms of allosteric effectors controlling one enzyme in glycolysis-phosphofructokinase. Under normal conditions of aerobic glycolysis both citrate and the ATP/AMP ratio increase, and since citrate and ATP are allosteric inhibitors of phosphofructokinase glycolysis is decreased. Subsequently when the ATP and citrate levels fall, due to metabolic utilization, the inhibition of phosphofructokinase is released and glycolysis is stimulated.
Under anaerobic conditions the concentrations of citrate and ATP decrease and AMP increases.
AMP is an allosteric de-inhibitor of phosphofructokinase and therefore glycolytic activity increases, resulting in more glucose being metabolized to give the same energy yield anaerobically. In this way the ATP level may be restored.
ATP inhibition is enhanced by an increase in the hydrogen ion concentration so that, in muscle, the rate of glycolysis may be slowed down if lactate concentration is too high. It has also been observed that a decreased hydrogen ion concentration leads to an increase in glycolysis especially in muscle.
(ii) Gluconeogenesis.
The regulatory enzyme in this pathway is fructose-l,6-diphosphatase which is an allosteric enzyme. AMP is a powerful allosteric inhibitor but lactate partially releases the inhibition of AMP. Thus high concentrations of AMP stimulate glycolysis and inhibit gluconeogenesis.
Gluconeogenesis supplies glucose from liver and kidney cortex to maintain the blood sugar level. This pathway is particularly active during starvation. The principal source of energy is fatty acid metabolism which increases the mitochondrial NADH/NAD ratio. The reducing equivalents generated in the mitochondria are transferred to the cytosol by reversal of the "shuttle" mechanism shown in figure 3 . This allows reduction of 1,3-diphosphoglycerate to glyceraldehyde-3-phosphate and thereby provides precursors for the functioning of fructose-l,6-diphosphate in the gluconeogenic pathway (fig. 4) .
In addition the mitochondrial production of NADH provides fuel for respiratory chain phosphorylation and the ATP produced inhibits glycolysis by phosphofructokinase inhibition. Because fat catabolism produces acetyl CoA the reaction (i) (fig. 4 ) is stimulated and pyruvate is converted to oxaloacetate (the first step in gluconeogenesis). Finally, lactate conversion to pyruvate supplies NADH, the importance of which has already been stressed.
The enzyme NAD-dependent isocitrate dehydrogenase ( fig. 5 ) is considered to be a regulatory enzyme in the citrate cycle. It is activated by high concentrations of ADP and AMP. Thus when the ATP/AMP ratio is low this enzyme is stimulated so that the flow of NADH along the electron transport system will increase and the AMP and ADP will be converted into ATP and the enzyme reaction will revert to its normal velocity. In addition there is inhibition by NADH. Thus, if the electron transport system cannot handle the NADH produced by isocitrate dehydrogenase, then this enzyme reaction is slowed down. This is the situation in hypoxia.
(iv) Electron transport system and oxidative phosphorylation. The flow of NADH from the citrate cycle can be controlled by isocitrate dehydrogenase but the availability of ADP and P are also regulatory features because the reaction ADP + P->ATP obviously requires a sufficient supply of precursors. Thus when the ATP/ADP ratio is high there will be little ADP available for phosphorylation. Under these circumstances isocitrate dehydrogenase will not be stimulated and phosphofructokinase will be inhibited and thus all the main metabolic pathways will be slowed down until the high level of ATP is reduced.
SECTION III: ANOXIA
The intracellular events during anoxia can be envisaged as follows although all the steps described have not yet been experimentally verified. As the Po 2 falls: (i) Electron transport along the cytochrome chain is reduced and there is an increased mitochondrial NADH content. The ATP level necessarily drops.
(ii) The increased NADH level inhibits isocitrate dehydrogenase activity and acetyl CoA formation from pyruvate is reduced because this reaction requires NAD. This leads to a reduced citrate level.
(iii) Reduction of citrate and ATP levels releases the phosphofructokinase inhibition (allosteric effect) thus allowing the rate of glycolysis to increase (reverse Pasteur effect). Thus the ATP level will increase.
(iv) Pyruvate and NADH will accumulate in the cytosol. NADH can no longer be removed by the mechanism illustrated in figure 3 because it is dependent on mitochondrial NADH oxidation. The lactate dehydrogenase reaction (pyruvate + NADH ^^lactate + NAD) reduces the intracellular level of NADH (and pyruvate) thus allowing glycolysis to continue because NAD is required for the phosphoglyceraldehyde dehydrogenase reaction ( fig. 1 ). Lactate and pyruvate will diffuse out of the cell into the blood, where their presence may be noted under clinical conditions (McDowall, 1969) .
CONCLUSION
The chemical anatomy of the cell is related to the compartmentation of metabolic pathways and their regulation by intracellular metabolites. The glycolytic and gluconeogenic pathways are of primary importance for the generation and dispersal of cytoplasmic NADH. There are tissue variations in metabolic pathways. Anoxia seriously disturbs intracellular carbohydrate utilization.
